Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 85451-85500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05149911
Effect of a Life Coaching Intervention on the Well-being and Distress of Physicians
NARecruiting
180 participants
Started: Jul 14, 2022 · Completed: Nov 28, 2025
2 conditions3 sponsors1 location
NCT05182931
A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
PHASE2Recruiting
80 participants
Started: Jul 14, 2022 · Completed: Dec 30, 2025
1 condition10 sponsors9 locations
NCT05931562
The Impact of Diet on the Gut-Microbiota-Brain Axis
NARecruiting
200 participants
Started: Jul 14, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05422716
"Epidural Spinal Cord Stimulation: Addressing Spasticity and Motor Function"
NANot yet recruiting
20 participants
Started: Jul 14, 2022 · Completed: May 15, 2026
1 condition1 sponsor0 locations
NCT05357469
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
NARecruiting
38 participants
Started: Jul 14, 2022 · Completed: Jul 31, 2025
1 condition3 sponsors1 location
NCT05526573
Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions
N/ARecruiting
148 participants
Started: Jul 14, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor3 locations
NCT05126277
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
PHASE3Recruiting
420 participants
Started: Jul 14, 2022 · Completed: Nov 5, 2030
1 condition1 sponsor188 locations
NCT05632380
ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)
PHASE1/PHASE2Recruiting
20 participants
Started: Jul 14, 2022 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT05648474
Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure
N/ARecruiting
400 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT05444920
The Italian Transthyretin Amyloidosis Web-Network
N/ARecruiting
1,000 participants
Started: Jul 13, 2022 · Completed: Nov 1, 2027
1 condition1 sponsor1 location
NCT05130840
Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer
NARecruiting
20 participants
Started: Jul 13, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05404880
INSPIRIS China PMCF Study
N/AActive, not recruiting
255 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2029
1 condition4 sponsors13 locations
NCT05512234
Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic
NARecruiting
102 participants
Started: Jul 13, 2022 · Completed: Oct 30, 2025
1 condition3 sponsors2 locations
NCT06163976
Prognostic Modelling for Prediction of Mortality and Functional Disability in Critically-ill Elderly Patients
N/ARecruiting
329 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2024
4 conditions4 sponsors4 locations
NCT05446259
Degenerative Cervical Myelopathy Repository
N/ARecruiting
245 participants
Started: Jul 13, 2022 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05019716
Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Etoposide and Cisplatin) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
PHASE1/PHASE2Recruiting
55 participants
Started: Jul 13, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor5 locations
NCT05488340
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
PHASE2Recruiting
318 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors20 locations
NCT05475925
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
PHASE1/PHASE2Recruiting
69 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2026
13 conditions1 sponsor36 locations
NCT05200260
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
PHASE2Recruiting
220 participants
Started: Jul 13, 2022 · Completed: Jun 30, 2027
3 conditions2 sponsors9 locations
NCT05045430
PMS Study to Confirm the Ongoing Safety and Performance of Silver II Non-woven Dressing in Chronic and Acute Wounds
NARecruiting
240 participants
Started: Jul 13, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors6 locations
NCT05667857
Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Advanced Cancer Survivors Treated With Immunotherapy and the Efficacy of Integrative Neurocognitive Remediation Therapy
NARecruiting
100 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2033
9 conditions2 sponsors2 locations
NCT05384756
TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
PHASE1Recruiting
20 participants
Started: Jul 13, 2022 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT05463913
Lung Nodule Detection Using Ultra-long FOV PET/CT
PHASE4Recruiting
20 participants
Started: Jul 13, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05392114
A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
PHASE3Active, not recruiting
154 participants
Started: Jul 13, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor50 locations
NCT04940663
Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
NARecruiting
120 participants
Started: Jul 13, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT05142696
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab
PHASE1/PHASE2Recruiting
200 participants
Started: Jul 13, 2022 · Completed: Mar 23, 2029
1 condition1 sponsor47 locations
NCT05257551
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
N/ARecruiting
50 participants
Started: Jul 13, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors11 locations
NCT05198960
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
PHASE3Recruiting
1,308 participants
Started: Jul 13, 2022 · Completed: Jul 13, 2027
5 conditions1 sponsor42 locations
NCT05708131
Outcomes of Functional Substrate Mapping of Ventricular Tachycardia
N/ARecruiting
70 participants
Started: Jul 13, 2022 · Completed: Dec 1, 2024
1 condition2 sponsors8 locations
NCT05316935
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
PHASE2/PHASE3Recruiting
80 participants
Started: Jul 13, 2022 · Completed: Mar 30, 2027
3 conditions1 sponsor2 locations
NCT06390904
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients
PHASE2/PHASE3Active, not recruiting
29 participants
Started: Jul 13, 2022 · Completed: Jul 30, 2027
3 conditions1 sponsor2 locations
NCT06379113
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
PHASE2/PHASE3Recruiting
29 participants
Started: Jul 13, 2022 · Completed: Mar 30, 2027
4 conditions1 sponsor2 locations
NCT05406713
Pembrolizumab in Muscle-invasive Bladder Cancer
PHASE2Active, not recruiting
46 participants
Started: Jul 13, 2022 · Completed: Jan 31, 2028
3 conditions2 sponsors4 locations
NCT05233618
Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)
PHASE1Recruiting
44 participants
Started: Jul 13, 2022 · Completed: Oct 1, 2026
3 conditions1 sponsor2 locations
NCT05246514
A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
PHASE2Active, not recruiting
72 participants
Started: Jul 13, 2022 · Completed: Mar 16, 2026
1 condition2 sponsors28 locations
NCT05452122
Decoding and Selective Modulation of Human Memory During Awake/Sleep Cycles
NARecruiting
150 participants
Started: Jul 13, 2022 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT05278351
Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC
PHASE2Recruiting
87 participants
Started: Jul 13, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05362773
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies
PHASE1Recruiting
130 participants
Started: Jul 13, 2022 · Completed: May 31, 2027
8 conditions1 sponsor7 locations
NCT05131100
Korean Regulatory Post Marketing Surveillance for Somavert
N/ARecruiting
100 participants
Started: Jul 13, 2022 · Completed: Sep 15, 2026
1 condition1 sponsor1 location
NCT05406830
Efficacy Study of Acupuncture on Asymptomatic Hyperuricemia
NARecruiting
180 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT05381155
Tackling Intrusive Traumatic Memories After Childbirth
NARecruiting
120 participants
Started: Jul 13, 2022 · Completed: Dec 30, 2024
2 conditions1 sponsor2 locations
NCT05469854
A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate
PHASE1Recruiting
113 participants
Started: Jul 13, 2022 · Completed: Dec 2, 2024
4 conditions1 sponsor1 location
NCT05106608
Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study
NARecruiting
60 participants
Started: Jul 13, 2022 · Completed: Jul 31, 2026
3 conditions1 sponsor1 location
NCT05302752
Quantification and Repeatability of Magnetic Stimulation
NAActive, not recruiting
16 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05226780
Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE
PHASE2Active, not recruiting
8 participants
Started: Jul 12, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor4 locations
NCT05111223
Testing the Contribution of Orbitofrontal Cortex Networks to Decision-making
NARecruiting
120 participants
Started: Jul 12, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05353647
A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)
PHASE2Active, not recruiting
25 participants
Started: Jul 12, 2022 · Completed: Jul 31, 2027
1 condition5 sponsors9 locations
NCT04896931
New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
N/ARecruiting
200 participants
Started: Jul 12, 2022 · Completed: Sep 30, 2029
2 conditions1 sponsor25 locations
NCT07133789
The Contribution of Optical Mapping to the Characterization of Chromosomal Rearrangements in Patients With Neurodevelopmental Disorders
N/ARecruiting
105 participants
Started: Jul 12, 2022 · Completed: Aug 19, 2025
1 condition1 sponsor1 location
NCT04191460
Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer
PHASE2Recruiting
28 participants
Started: Jul 12, 2022 · Completed: Jul 1, 2025
3 conditions1 sponsor1 location